Factors associated with children's HIV- positive status disclosure in Wolaita Zone, Southern Ethiopia: a cross-sectional study.
ART
Children
Disclosure
Ethiopia
HIV/AIDS
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
06 Jun 2022
06 Jun 2022
Historique:
received:
22
02
2022
accepted:
27
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Children's HIV-positive status disclosure is an essential component of chronic care & long-term disease management. The modalities of status disclosure are complex and vary across different communities. Although data from various settings are necessary to overcome this problem, evidence is limited, specifically in the in the study areas. Therefore, this study aimed to assess the prevalence of HIV-positive status disclosure and associated factors among children on antiretroviral therapy (ART). A mixed-method, facility-based study was conducted: among 203 caregivers with children in Wolaita Zone, Southern Ethiopia. We used in-depth interviews for qualitative data in addition to structured questionnaires. Simple random sampling for quantitative and purposive sampling for qualitative parts was applied. We used Content or Thematic analysis for qualitative and Binary logistic regression for quantitative. All the caregivers were interviewed and majorities (84.7%) of them were female. One hundred twelve children (55.2%) were below 12 years of age. In this study, the overall prevalence of children with HIV-positive status disclosure was 46.8%. Being 12 or more years of age (AOR = 7.5, 95% CI: 2.9-15.6), duration on ART 72 or more months (AOR = 3.8, 95% CI: 1.7-6.7), death of the parent (AOR = 2.0, 95% CI: 1.1- 3.8), and having follow up in the hospital (AOR = 2.1, 95% CI: 1.3-4.7) were associated with disclosure. Being an immature child was the commonest reason cited by caregivers for non-disclosure. Frequent questions by the child about why they are taking drugs, for better self-care, and treatment adherence were the commonest reason of caregivers for disclosing their children's HIV-positive status. In our study, children's HIV-positive status disclosure was significantly low. This study identified different factors (Health facility, children, and caregivers-related factors) as the main reason for disclosing children's HIV-positive status. Hence, health care workers should give special attention to children's HIV-positive status disclosure, which helps to increase the effectiveness of treatment and prevent further HIV transmission.
Sections du résumé
BACKGROUND
BACKGROUND
Children's HIV-positive status disclosure is an essential component of chronic care & long-term disease management. The modalities of status disclosure are complex and vary across different communities. Although data from various settings are necessary to overcome this problem, evidence is limited, specifically in the in the study areas. Therefore, this study aimed to assess the prevalence of HIV-positive status disclosure and associated factors among children on antiretroviral therapy (ART).
METHODS
METHODS
A mixed-method, facility-based study was conducted: among 203 caregivers with children in Wolaita Zone, Southern Ethiopia. We used in-depth interviews for qualitative data in addition to structured questionnaires. Simple random sampling for quantitative and purposive sampling for qualitative parts was applied. We used Content or Thematic analysis for qualitative and Binary logistic regression for quantitative.
RESULTS
RESULTS
All the caregivers were interviewed and majorities (84.7%) of them were female. One hundred twelve children (55.2%) were below 12 years of age. In this study, the overall prevalence of children with HIV-positive status disclosure was 46.8%. Being 12 or more years of age (AOR = 7.5, 95% CI: 2.9-15.6), duration on ART 72 or more months (AOR = 3.8, 95% CI: 1.7-6.7), death of the parent (AOR = 2.0, 95% CI: 1.1- 3.8), and having follow up in the hospital (AOR = 2.1, 95% CI: 1.3-4.7) were associated with disclosure. Being an immature child was the commonest reason cited by caregivers for non-disclosure. Frequent questions by the child about why they are taking drugs, for better self-care, and treatment adherence were the commonest reason of caregivers for disclosing their children's HIV-positive status.
CONCLUSION
CONCLUSIONS
In our study, children's HIV-positive status disclosure was significantly low. This study identified different factors (Health facility, children, and caregivers-related factors) as the main reason for disclosing children's HIV-positive status. Hence, health care workers should give special attention to children's HIV-positive status disclosure, which helps to increase the effectiveness of treatment and prevent further HIV transmission.
Identifiants
pubmed: 35668505
doi: 10.1186/s13052-022-01287-6
pii: 10.1186/s13052-022-01287-6
pmc: PMC9169329
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Informations de copyright
© 2022. The Author(s).
Références
Front Public Health. 2017 Aug 30;5:231
pubmed: 28913332
BMC Public Health. 2016 Oct 13;16(1):1083
pubmed: 27737669
BMC Public Health. 2015 Oct 07;15:1028
pubmed: 26445104
BMC Int Health Hum Rights. 2017 Apr 8;17(1):8
pubmed: 28388947
Reprod Health. 2017 Aug 30;14(1):107
pubmed: 28854944
PLoS One. 2015 Jul 13;10(7):e0132691
pubmed: 26167687
BMC Pediatr. 2018 Nov 15;18(1):356
pubmed: 30442118
Int J STD AIDS. 2016 Mar;27(4):288-95
pubmed: 25829519
J Infect Public Health. 2019 Nov - Dec;12(6):873-877
pubmed: 31213410
PLoS One. 2011 Mar 21;6(3):e17572
pubmed: 21445289
BMC Pediatr. 2018 Aug 18;18(1):272
pubmed: 30121082
AIDS Care. 2016 Aug;28(8):1046-51
pubmed: 26883299
Pediatrics. 1999 Jan;103(1):164-6
pubmed: 9917458
Pediatric Health Med Ther. 2021 Jun 25;12:299-306
pubmed: 34211313
BMJ Open. 2018 Aug 30;8(8):e019554
pubmed: 30166287
SAHARA J. 2016 Dec;13(1):136-41
pubmed: 27580966
Med Ref Serv Q. 2020 Jan-Mar;39(1):67-74
pubmed: 32069199
J Multidiscip Healthc. 2020 Jun 16;13:507-517
pubmed: 32606722
J Dev Behav Pediatr. 2016 Jul-Aug;37(6):496-505
pubmed: 27262128
BMC Pediatr. 2018 Nov 22;18(1):365
pubmed: 30466425
Front Public Health. 2017 Dec 13;5:343
pubmed: 29326918
PLoS One. 2016 Feb 16;11(2):e0148950
pubmed: 26881773
J Acquir Immune Defic Syndr. 2017 May 1;75(1):18-26
pubmed: 28114186
Afr Health Sci. 2015 Jun;15(2):344-51
pubmed: 26124778